The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reliability of real-world data for diagnosis of metastatic prostate cancer.
 
Christina Phuong
No Relationships to Disclose
 
Amy M. Lin
No Relationships to Disclose
 
Izzy Friesner
Leadership - Shrodinger (I)
Stock and Other Ownership Interests - Shrodinger (I)
Consulting or Advisory Role - Shrodinger (I)
Patents, Royalties, Other Intellectual Property - Shrodinger (I)
 
Lisa Ni
No Relationships to Disclose
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Alessa Therapeutics; Alessa Therapeutics; Amgen; AstraZeneca; Axiom Biotechnologies; Clovis Oncology; Dendreon; Jubilant Pharmaceuticals; Merck; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BioXCel therapeutics (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
 
Hala Borno
Employment - Collective Health (I); Trial Library; Waymark (I)
Leadership - Collective Health (I); Waymark (I)
Stock and Other Ownership Interests - Collective Health (I); Trial Library; Waymark (I)
Honoraria - AstraZeneca; BMS; ConcertAI; Dendreon
Consulting or Advisory Role - AstraZeneca; BMS; Dendreon
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte; Janssen Oncology; Nektar; Taiho Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Arpita Desai
Consulting or Advisory Role - Dendreon; Janssen Oncology
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - Astellas Scientific and Medical Affairs Inc; AstraZeneca/MedImmune; EMD Serono
Consulting or Advisory Role - Abbvie; Astellas Pharma; Basilea; Dava Oncology; Dendreon; EMD Serono; Foundation Medicine; Merck
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen; Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Jounce Therapeutics
 
Lawrence Fong
Stock and Other Ownership Interests - Actym Therapeutics; Alector; Atreca; BioAtla; Bolt Biotherapeutics; ImmunoGenesis; Nutcracker Therapeutics, Inc.; RAPT Therapeutics; Senti Biosciences; SOTERIA Precision Medicine; Sutro Biopharma
Consulting or Advisory Role - Alector; AstraZeneca; Atreca; BioAtla; Bolt Biotherapeutics; Bristol-Myers Squibb; Dendreon; EMD Serono; Innovent Biologics; Janssen Oncology; Merck; Nutcracker Therapeutics, Inc.; RAPT Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Rohit Bose
No Relationships to Disclose
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Atara Biotherapeutics (I); Bluebird Bio (I); Celgene (I); Exelixis (I)
Consulting or Advisory Role - exai bio
Research Funding - Amgen (Inst)
 
Tammy J. Rodvelt
No Relationships to Disclose
 
Osama Mohamad
Research Funding - Salesforce; Salesforce
 
Anthony C. Wong
No Relationships to Disclose
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics
 
Julian C. Hong
Patents, Royalties, Other Intellectual Property - Inventor on pending patent, "Systems and methods for predicting acute care visits during outpatient cancer therapy"